FREDERICK, Md. (AP) — MedImmune says it will share its manufacturing space in Frederick with pharmaceutical giant Merck & Co.
MedImmune said Wednesday the companies have reached a 15-year deal allowing Merck to use its 385,000-square-foot plant for bulk product manufacturing.
MedImmune says it’s also looking at Merck’s facilities for possible production of microbial-based compounds MedImmune is developing.
MedImmune says it’s not unusual in the biopharmaceutical industry for companies to share manufacturing capacity.
MedImmune is a Gaithersburg-based subsidiary of London-based AstraZeneca PLC.
Merck is based in Whitehouse Station, N.J.
(Copyright 2011 by The Associated Press. All Rights Reserved.)